# TBT Pharma, Inc. — Form D

TBT Pharma, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-05. The offering totals $2.0M, of which $700K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-01-05
- Form: D
- Accession: 0001838968-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $700K
- Remaining: $1.3M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2020-12-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-385235

## Issuer

- Name: TBT Pharma, Inc.
- CIK: 0001838968
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 708 HANOVER STREET, BALTIMORE, MD, 21230
- Phone: 9146725006

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Neil Cohen | Director | Dallas, TX |
| Steve Girgenti | Director | Bellmore, NY |
| Ian Tolfree | Director | Baltimore, MD |
| Ian Tolfree | Executive Officer | Baltimore, MD |
| Ian Tolfree | Promoter | Baltimore, MD |

## More

- [CIK 1838968 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1838968&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001838968-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.